Overall rank by patents
#6,837
of 50,000 tracked assignees
USPTO PatentsView assignee record - 49 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, Seegene ranks #6,837 of 50,000 tracked US assignees by granted-patent volume, with 49 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R6837 · Foreign Corporation #6,837 · 49 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Qliktech International AB (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Clean Power Research… · near
47 score
Electro Industries/g… · near
47 score
Health Research · near
47 score
Seegene · this assignee
47 score
Slayback Pharma · near
47 score
3D Lighting Innovati… · lowest
7 score
What this shows Seegene, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-UP, BOOK-FULL. Volume places it #6,837 of 50,000; Innovation Score 47.4/100 sits in the top 19% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Qliktech International AB (±0 grants).
Seegene, Inc. has been granted 49 US utility patents between 2016 and 2025, placing Seegene, Inc. at #6,837 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a Foreign Corporation, Seegene, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Seegene sits between Qliktech International AB (49 patents, rank #6,830) and Switch, Ltd. (49 patents, rank #6,838) - the closest US assignees by grant volume. The composite Innovation Score of 47.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 25 grants, compared with 17 in the 2015–2019 window, a +47% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Seegene, Inc.'s 17.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
QlikTech International AB
49 patents
REATA PHARMACEUTICALS HOLDINGS, LLC
49 patents
RIMOWA GmbH
49 patents
Relievant Medsystems, Inc.
49 patents
SKF Magnetic Mechatronics
49 patents
STANDARD COGNITION, CORP.
49 patents
STMicroelectronics Design & Application S.R.O.
49 patents
SWITCH, LTD.
49 patents
SEEGENE, INC.
49 patents
What this shows Seegene holds 49 patents at rank #6,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,834 in granted patent volume.
Other assignees with the most granted patents in Seegene's primary technology class.
Two PlainPatent-derived peer sets for Seegene, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (47 here).
Seegene's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 6.1% |
| 2017 | 7 | 14.3% |
| 2018 | 5 | 10.2% |
| 2019 | 2 | 4.1% |
| 2020 | 5 | 10.2% |
| 2021 | 3 | 6.1% |
| 2022 | 7 | 14.3% |
| 2023 | 6 | 12.2% |
| 2024 | 4 | 8.2% |
| 2025partial year | 7 | 14.3% |
Top 12 of 12 technology areas
Overall rank by patents
#6,837
of 50,000 tracked assignees
47.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.